Renovaro Biosciences Inc. (RENB)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.71

-3.39%

After-hours Dec 13, 2024, 06:08 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Revenue	-	-	-	-	-	-	-	-	42.77K
Cost of Revenue	121.86K	113.50K	123.59K	391.42K	366.27K	71.71K	18.48K	14.53K	32.67K
Gross Profit	-121.86K	-113.50K	-123.59K	-391.42K	-366.27K	-71.71K	-18.48K	-14.53K	10.10K
Operating Income	-81.64M	-38.56M	-116.08M	-23.40M	-11.92M	-10.99M	-3.24M	-2.40M	-2.12M
Interest Income	-	-	122.04K	13.18K	50.30K	73.49K	45.82K	-	-
Pretax Income	-80.65M	-39.68M	-113.43M	-26.85M	-11.42M	-18.02M	-6.42M	-2.21M	-2.20M
Net Income	-80.65M	-39.68M	-113.43M	-26.72M	-11.42M	-18.02M	-6.31M	-2.14M	-1.74M
Selling & General & Admin	24.56M	15.32M	14.33M	7.56M	7.12M	8.42M	2.60M	2.32M	1.33M
Research & Development	2.71M	4.17M	8.37M	15.72M	4.69M	2.50M	616.96K	62.76K	804.19K
Other Expenses	54.37M	-	-	-	-	-	-	-	-
Operating Expenses	81.64M	19.60M	22.83M	23.40M	11.92M	10.92M	3.22M	2.39M	2.13M
Interest Expense	1.01M	706.96K	372.84K	379.61K	104.28K	43.00	143.26K	26.26K	2.36K
Selling & Marketing Expenses	383.55K	-	-	-	-	-	-	-	-
Cost & Expenses	81.64M	19.60M	22.83M	23.40M	11.92M	10.99M	3.24M	2.40M	2.16M
Income Tax	-	706.96K	34.00	-125.28K	104.28K	1.00	-111.72K	-64.88K	-462.79K
Shares Outstanding (Basic)	96.25M	56.27M	52.53M	47.17M	46.33M	37.55M	21.94M	12.27M	9.53M
Shares Outstanding (Diluted)	96.25M	56.27M	52.53M	47.17M	46.33M	37.55M	21.94M	12.27M	9.53M
EPS (Basic)	-0.84	-0.71	-2.16	-0.57	-0.25	-0.48	-0.29	-0.17	-0.18
EPS (Diluted)	-0.84	-0.71	-2.16	-0.57	-0.25	-0.48	-0.29	-0.17	-0.18
EBITDA	-79.52M	-19.48M	-22.70M	-23.28M	-11.51M	-17.94M	-5.31M	-2.39M	-2.17M
Depreciation & Amortization	121.86K	113.50K	123.59K	123.53K	366.27K	71.71K	18.48K	14.53K	27.39K